Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial) Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial)

Analytical Performance Characteristics should be Judged Against Objective Quality Specifications (Editorial‪)‬

Clinical Chemistry 1999, March, 45, 3

Clinical Chemistry
    • $5.99
    • $5.99

Publisher Description

The discipline of clinical chemistry is dynamic. Even a superficial glance at contents pages of the journal over recent years demonstrates a marked evolution of the field. Appropriately, the Information for authors has also changed over the years to reflect new concepts of what constitutes an acceptable publication. Readers of the Journal may have noticed an addition to the 1999 Information for authors (1), under the heading Description of Analytical Methods and Results, namely:

GENRE
Science & Nature
RELEASED
1999
March 1
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
American Association for Clinical Chemistry, Inc.
SELLER
The Gale Group, Inc., a Delaware corporation and an affiliate of Cengage Learning, Inc.
SIZE
182.2
KB

More Books Like This

Pharmaceutical Analysis for Small Molecules Pharmaceutical Analysis for Small Molecules
Pharmaceutical Analysis for Small Molecules
2017
Principles and Practice of Clinical Research Principles and Practice of Clinical Research
Principles and Practice of Clinical Research
2017
Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion) Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
Panel Discussion: How to Monitor and Minimize Variation and Mistakes (Clinical Chemistry Forum) (Discussion)
1997
Proposals to Enhance the Quality of Observational Cohort Studies (Review) Proposals to Enhance the Quality of Observational Cohort Studies (Review)
Proposals to Enhance the Quality of Observational Cohort Studies (Review)
2003
Reporting Bias in Diagnostic and Prognostic Studies: Time for Action (Editorial) Reporting Bias in Diagnostic and Prognostic Studies: Time for Action (Editorial)
Reporting Bias in Diagnostic and Prognostic Studies: Time for Action (Editorial)
2008
Quality: The Next Six Months (Clinical Chemistry Forum) Quality: The Next Six Months (Clinical Chemistry Forum)
Quality: The Next Six Months (Clinical Chemistry Forum)
1997

More Books by Clinical Chemistry

Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial) Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
Doping in Sport: Misuse, Analytical Tests, And Legal Aspects (Editorial)
1997
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report) Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
Vitamin E and Coronary Heart Disease in Tunisians (Nutrition) (Clinical Report)
2000
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey) Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
Endothelial Nitric Oxide Synthase Haplotypes Are Associated with Features of Metabolic Syndrome (Endocrinology and Metabolism) (Survey)
2007
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor) Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
Alanine Aminotransferase As an Independent Predictor of Incident Nonalcoholic Fatty Liver Disease (Letters) (Letter to the Editor)
2007
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology) T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
T-Cell Regulatory Gene CTLA-4 Polymorphism/Haplotype Association with Autoimmune Pancreatitis (Clinical Immunology)
2007
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers) Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
Percent Free Prostate-Specific Antigen in Assessing the Probability of Prostate Cancer Under Optimal Analytical Conditions (Enzymes and Protein Markers)
1998